Home Healthcare Pharmaceuticals Menopause Market

Menopause Market Size, Share & Trends Analysis Report By Treatment Type (Dietary Supplements, Hormone Therapies, Non-hormonal Therapies), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Other Distribution Channels) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: February 12, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Menopause Market Size Analysis
    1. Introduction
    2. Menopause Market Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
      1. Dietary Supplements
        1. Multivitamin Supplements
        2. Phytoestrogen Supplement
        3. Antioxidant Supplements
        4. Other Supplements
      2. Hormone Therapies
        1. Progestin-only Medicines
        2. Estrogen-only Medicines
        3. Other Therapies
        4. DNA Polymerases
      3. Non-hormonal Therapies
        1. Gabapentinoids
        2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
        3. Selective Serotonin Reuptake Inhibitors (SSRI)
        4. Other Non-hormonal Therapies
    3. Menopause Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Other Distribution Channels
  7. North America Menopause Market Size Analysis
    1. Introduction
    2. Menopause Market Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
      1. Dietary Supplements
        1. Multivitamin Supplements
        2. Phytoestrogen Supplement
        3. Antioxidant Supplements
        4. Other Supplements
      2. Hormone Therapies
        1. Progestin-only Medicines
        2. Estrogen-only Medicines
        3. Other Therapies
        4. DNA Polymerases
      3. Non-hormonal Therapies
        1. Gabapentinoids
        2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
        3. Selective Serotonin Reuptake Inhibitors (SSRI)
        4. Other Non-hormonal Therapies
    3. Menopause Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Other Distribution Channels
    4. U.S.
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    5. Canada
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
  8. Europe Menopause Market Size Analysis
    1. Introduction
    2. Menopause Market Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
      1. Dietary Supplements
        1. Multivitamin Supplements
        2. Phytoestrogen Supplement
        3. Antioxidant Supplements
        4. Other Supplements
      2. Hormone Therapies
        1. Progestin-only Medicines
        2. Estrogen-only Medicines
        3. Other Therapies
        4. DNA Polymerases
      3. Non-hormonal Therapies
        1. Gabapentinoids
        2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
        3. Selective Serotonin Reuptake Inhibitors (SSRI)
        4. Other Non-hormonal Therapies
    3. Menopause Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Other Distribution Channels
    4. U.K.
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    5. Germany
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    6. France
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    7. Spain
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    8. Italy
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    9. Russia
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    10. Nordic
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    11. Benelux
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    12. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
  9. APAC Menopause Market Size Analysis
    1. Introduction
    2. Menopause Market Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
      1. Dietary Supplements
        1. Multivitamin Supplements
        2. Phytoestrogen Supplement
        3. Antioxidant Supplements
        4. Other Supplements
      2. Hormone Therapies
        1. Progestin-only Medicines
        2. Estrogen-only Medicines
        3. Other Therapies
        4. DNA Polymerases
      3. Non-hormonal Therapies
        1. Gabapentinoids
        2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
        3. Selective Serotonin Reuptake Inhibitors (SSRI)
        4. Other Non-hormonal Therapies
    3. Menopause Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Other Distribution Channels
    4. China
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    5. Korea
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    6. Japan
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    7. India
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    8. Australia
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    9. Taiwan
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    10. South East Asia
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    11. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
  10. Middle East and Africa Menopause Market Size Analysis
    1. Introduction
    2. Menopause Market Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
      1. Dietary Supplements
        1. Multivitamin Supplements
        2. Phytoestrogen Supplement
        3. Antioxidant Supplements
        4. Other Supplements
      2. Hormone Therapies
        1. Progestin-only Medicines
        2. Estrogen-only Medicines
        3. Other Therapies
        4. DNA Polymerases
      3. Non-hormonal Therapies
        1. Gabapentinoids
        2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
        3. Selective Serotonin Reuptake Inhibitors (SSRI)
        4. Other Non-hormonal Therapies
    3. Menopause Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Other Distribution Channels
    4. UAE
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    5. Turkey
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    6. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    7. South Africa
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    8. Egypt
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    9. Nigeria
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    10. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
  11. LATAM Menopause Market Size Analysis
    1. Introduction
    2. Menopause Market Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
      1. Dietary Supplements
        1. Multivitamin Supplements
        2. Phytoestrogen Supplement
        3. Antioxidant Supplements
        4. Other Supplements
      2. Hormone Therapies
        1. Progestin-only Medicines
        2. Estrogen-only Medicines
        3. Other Therapies
        4. DNA Polymerases
      3. Non-hormonal Therapies
        1. Gabapentinoids
        2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
        3. Selective Serotonin Reuptake Inhibitors (SSRI)
        4. Other Non-hormonal Therapies
    3. Menopause Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Other Distribution Channels
    4. Brazil
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    5. Mexico
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    6. Argentina
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    7. Chile
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    8. Colombia
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    9. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
  12. Competitive Landscape
    1. Menopause Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Pfizer Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Johnson & Johnson Inc.
    3. Merck & Co., Inc.
    4. Bayer AG
    5. AbbVie Inc.
    6. Novartis AG
    7. Novo Nordisk A/S
    8. Lilly
    9. Teva Pharmaceutical Industries Ltd.
    10. GSK plc
    11. Astellas Pharma Inc.
    12. Sanofi
    13. Pure Encapsulations, LLC
    14. Reddy’s Laboratories Ltd.
    15. Theramex 
    16. Midi Health
    17. Lindus Health
    18. Frieda Health
    19. Ipsen S.A.
    20. Endo International plc
    21. Hims & Hers Health
    22. Bonafide Health
    23. Elektra Health
    24. Oscar Health
    25. Hoag
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.